Patents by Inventor Kanianthara G. Chandy

Kanianthara G. Chandy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay, methods and products based on n K.sup.+ channel expression
    Patent number: 5827655
    Abstract: This disclosure relates to the n K.sup.+ channel expression product of the MK3 gene or a functionally bioactive equivalent thereof and its uses, particulary in combination with identifying immune responses and materials modulating or blocking same.
    Type: Grant
    Filed: September 12, 1995
    Date of Patent: October 27, 1998
    Assignee: The Regents of the University of California
    Inventors: Kanianthara G. Chandy, Michael D. Cahalan, Stephan Grissmer, Alan L. Goldin, Brent A. Dethlefs, George A. Gutman, John J. Wasmuth
  • Voltage-gated potassium channel gene, KV1.7, vectors and host cells comprising the same, and recombinant methods of making potassium channel proteins
    Patent number: 5559009
    Abstract: This disclosure relates to the identification of a new voltage-gated potassium channel gene, Kv1.7, which is expressed in pancreatic .beta.-cells. The invention utilizes this new potassium channel for assays designed to identify extrinsic materials with the ability to modulate said channel for the development of therapeutics effective in the treatment of non-insulin-dependent diabetes mellitus.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: September 24, 1996
    Assignee: The Regents of The University of California
    Inventors: Kanianthara G. Chandy, Katalin Kalman, Grischa Chandy, George A. Gutman
  • Assay for and treatment of autoimmune diseases
    Patent number: 5397702
    Abstract: This disclosure relates to the general diagnosis and treatment of autoimmune diseases with materials identified in assays based upon the finding herein that such diseases manifest by elevated numbers of type l K.sup.+ channels in abnormal CD4.sup.- CD8.sup.- T cells.
    Type: Grant
    Filed: October 2, 1992
    Date of Patent: March 14, 1995
    Assignee: The Regents of the University of California
    Inventors: Michael D. Cahalan, Kanianthara G. Chandy, Stephan Grissmer, Sanjiu Ghanshani, George A. Gutman, Brent A. Dethlefs